Scott Stubbe serves as the Vice President of Clinical Operations. Mr. Stubbe has over 30 years of experience in the pharmaceutical and biotechnology industry primarily managing large operational teams for clinical trials ranging from early-stage to late-stage drug development. Prior to joining Viking, he was Executive Director of Clinical Operations at ACADIA Pharmaceuticals, Inc. At Acadia, Mr. Stubbe oversaw the conduct of two large global pivotal trials from initiation through NDA submission. Previously, Mr. Stubbe was the Senior Director of Clinical Operations at Arena Pharmaceuticals, Inc. At Arena he served as Senior Director of Clinical Operations. During his tenure he oversaw the clinical operations of the company’s lead obesity compound, BELVIQ® from Phase III initiation through NDA submission to its approval‎. He has also previously held positions at Biogen and Iqvia. Mr. Stubbe holds a BA in Psychology from San Diego State University, and an MBA from National University.